相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutants
Ju-Il Kang et al.
FEBS LETTERS (2012)
Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication
Philippe Metz et al.
HEPATOLOGY (2012)
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
Mostafa K. El Awady et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
New Insights into the Role of RNase L in Innate Immunity
Arindam Chakrabarti et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
The Oligoadenylate Synthetase Family: An Ancient Protein Family with Multiple Antiviral Activities
Helle Kristiansen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP
Krishnamurthy Malathi et al.
RNA (2010)
Distinct Antiviral Roles for Human 2′,5′-Oligoadenylate Synthetase Family Members against Dengue Virus Infection
Ren-Jye Lin et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression
Michael Kulka et al.
VIROLOGY (2009)
PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control
Ju-Il Kang et al.
VIRUS RESEARCH (2009)
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
Jean K. Lim et al.
PLOS PATHOGENS (2009)
Small self-RNA generated by RNase L amplifies antiviral innate immunity
Krishnamurthy Malathi et al.
NATURE (2007)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
The human 2′-5′oligoadenylate synthetase family:: Unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation
Ara G. Hovanessian et al.
BIOCHIMIE (2007)
2′-,5′-oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
K. -I. Kim et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon
P Targett-Adams et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Mapping of the human RNASEL promoter and expression in cancer and normal cells
AM Zhou et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector
KJ Helbig et al.
HEPATOLOGY (2005)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene
V Bonnevie-Nielsen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
T Kato et al.
GASTROENTEROLOGY (2003)
Newcastle disease virus V protein is a determinant of host range restriction
MS Park et al.
JOURNAL OF VIROLOGY (2003)
Genomic analysis of the host response to hepatitis C virus infection
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p
BH Dong et al.
RNA (2001)
分享论文
